EMMA KERKLINGH
Associate Director Business Development Scinus Cell Expansion BV
Emma Kerklingh is Associate Director Business Development at Scinus Cell Expansion, where she is involved in strategic commercial engagement for Osilaris™ across cell therapy development, clinical manufacturing and CDMO partnerships. Her work focuses on aligning controlled, bioreactor-based expansion technologies with the practical requirements of advanced therapy process development, including scalability, process robustness and manufacturability.
Seminars
Wednesday 15th July 2026
Osilaris™ for Controlled, Scalable Cell Expansion: Supporting Process Robustness from Development to Manufacturing
11:30 am
- Addressing the limitations of conventional 2D expansion workflows when cell therapy processes need to move towards closed, scalable and reproducible manufacturing
- Exploring how Osilaris™ supports controlled low-shear expansion with in-line process control to help maintain process-relevant quality attributes
- Discussing how automation-ready bioreactor processing can support clinical-to-commercial progression, decentralised manufacturing models and lower process variability
